Robert Michael
Chief Executive Officer presso TOBIRA THERAPEUTICS INC
Patrimonio netto: 18 M $ in data 31/03/2024
Profilo
Robert A. Michael è Chief Financial Officer & Executive Vice President di AbbVie, Inc. e Chief Executive Officer di Fremont Holding LLC, Chief Executive Officer di Tobira Therapeutics, Inc. e President & Director di Allergan Plc (che sono tutte filiali di AbbVie, Inc.). Il signor Michael fa anche parte del consiglio di amministrazione di AbbVie Biotherapeutics Ltd. Il signor Michael ha precedentemente ricoperto la posizione di controllore di divisione - catena di approvvigionamento alimentare presso Abbott Laboratories. Ha ricevuto un MBA dalla Anderson School of Management.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ABBVIE, INC.
0.01% | 29/02/2024 | 98 645 ( 0.01% ) | 18 M $ | 31/03/2024 |
Posizioni attive di Robert Michael
Società | Posizione | Inizio |
---|---|---|
ABBVIE INC. | President | 23/06/2022 |
ALLERGAN PLC | President | 08/05/2020 |
TOBIRA THERAPEUTICS INC | Chief Executive Officer | - |
AbbVie Biotherapeutics Ltd.
AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Founded in 2016, AbbVie Biotherapeutics Ltd. is a British company that functions as an investment holding company. Part of AbbVie, Inc., the private company is based in Maidenhead, UK. | Director/Board Member | 01/04/2019 |
Fremont Holding LLC
Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Chief Executive Officer | - |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | President | - |
AbbVie Ltd. (United Kingdom)
AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie Ltd. (United Kingdom) is a British company that develops advanced therapies through research and innovation. The private company is based in Maidenhead, UK and was founded in 2012. | President | 01/01/2022 |
Precedenti posizioni note di Robert Michael
Società | Posizione | Fine |
---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | 01/08/2012 |
Formazione di Robert Michael
Kelley School of Business | Undergraduate Degree |
UCLA Anderson School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
ABBVIE INC. | Health Technology |
Aziende private | 6 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Health Technology |
Tobira Therapeutics, Inc.
Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on October 6, 2006 and is headquartered in Madison, NJ. | Health Technology |
AbbVie Biotherapeutics Ltd.
AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Founded in 2016, AbbVie Biotherapeutics Ltd. is a British company that functions as an investment holding company. Part of AbbVie, Inc., the private company is based in Maidenhead, UK. | Finance |
Fremont Holding LLC
Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Health Technology |
AbbVie Ltd. (United Kingdom)
AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie Ltd. (United Kingdom) is a British company that develops advanced therapies through research and innovation. The private company is based in Maidenhead, UK and was founded in 2012. | Commercial Services |
- Borsa valori
- Insiders
- Robert Michael